Follow the 셀트리온제약 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 셀트리온제약 has recorded 97 public disclosures. Market capitalisation: €1,772.5bn. The latest transaction was disclosed on 10 April 2026 (Purchase). Among the most active insiders: 셀트리온. Every trade is openly available.
97
Insider Decl.
n/a
Thresholds
€16m
36 ops.
Buy Volume
n/a
4 ops.
Sell Volume
30Σ signal
Buys €16mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 17,449 of 29,062 companies
45.9
score / 100
Value
39
Quality
53
FCF yld3.5%
Earn yld2.0%
EV/EBITDA26.6x
ROE8.9%
Gross mgn31%
Net mgn7.2%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Celltrion Healthcare es una empresa farmacéutica surcoreana centrada en el desarrollo y la fabricación de medicamentos biosimilares. Cotiza en la Bolsa de Corea, XKRX.